or Try an Advanced Search...

    Technical Analysis for FTRE - Fortrea Holdings Inc.

    Grade Last Price % Change Price Change
    F 20.09 -3.41% -0.71
    FTRE closed down 3.41 percent on Friday, September 6, 2024, on 73 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical FTRE trend table...
    Date Alert Name Type % Chg
    Multiple of Ten Bullish Other 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Signal Line Cross Bearish -3.41%
    Stochastic Reached Oversold Weakness -3.41%
    Down 3 Days in a Row Weakness -3.41%
    Down 4 Days in a Row Weakness -3.41%
    Older End-of-Day Signals for FTRE ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Lower Bollinger Band 2 days ago
    Down 3% 2 days ago
    Lower Bollinger Band Support 2 days ago
    Down 2 % 2 days ago
    60 Minute Opening Range Breakdown 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    FTRE Chart by TradingView
    Basic chart:

    Profile

    Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. It offers phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. is based in Durham, North Carolina.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Clinical Research Clinical Pharmacology Contract Research Organizations Patient Access Solutions

    Is FTRE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Aug 18 Fortrea Holdings Second Quarter 2024 Earnings: Misses Expectations
    Aug 16 Insider Stock Buying Reaches US$1.08m On Fortrea Holdings
    Aug 14 Klarman's Baupost adds WilScot, Capri, exits Altice USA, among others
    Aug 12 Fortrea Holdings: Continued Troubles
    Aug 12 Fortrea Holdings Inc. (FTRE) Q2 2024 Earnings Call Transcript
    Aug 12 Fortrea Holdings Non-GAAP EPS of -$0.03 misses by $0.09, revenue of $662.4M misses by $25.99M
    Aug 12 Fortrea Reports Second Quarter 2024 Results
    Aug 12 Monday.com, Sun Life Financial And 3 Stocks To Watch Heading Into Monday
    Aug 8 Evercore cuts Fortrea to in line, cites weakening macro environment
    Jul 18 Demystifying Fortrea Holdings: Insights From 8 Analyst Reviews
    See more FTRE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 41.02
    52 Week Low 18.07
    Average Volume 1,407,982
    200-Day Moving Average 30.72
    50-Day Moving Average 24.18
    20-Day Moving Average 22.23
    10-Day Moving Average 22.08
    Average True Range 1.20
    RSI (14) 33.77
    ADX 29.58
    +DI 13.82
    -DI 34.55
    Chandelier Exit (Long, 3 ATRs) 22.98
    Chandelier Exit (Short, 3 ATRs) 21.68
    Upper Bollinger Bands 24.45
    Lower Bollinger Band 20.00
    Percent B (%b) 0.02
    BandWidth 20.05
    MACD Line -0.93
    MACD Signal Line -0.81
    MACD Histogram -0.1196
    Fundamentals Value
    Market Cap 1.78 Billion
    Num Shares 88.8 Million
    EPS 0.06
    Price-to-Earnings (P/E) Ratio 334.83
    Price-to-Sales 0.00
    Price-to-Book 0.00
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 22.13
    Resistance 3 (R3) 22.32 21.82 21.79
    Resistance 2 (R2) 21.82 21.30 21.73 21.68
    Resistance 1 (R1) 20.96 20.98 20.71 20.77 21.56
    Pivot Point 20.46 20.46 20.34 20.37 20.46
    Support 1 (S1) 19.60 19.94 19.35 19.41 18.62
    Support 2 (S2) 19.10 19.62 19.01 18.50
    Support 3 (S3) 18.24 19.10 18.39
    Support 4 (S4) 18.05